July 23, 2014 3:14 PM ET

Healthcare Equipment and Supplies

Company Overview of Mediwatch plc

Company Overview

Mediwatch plc, through its subsidiaries, engages in the development and marketing of medical devices used in the diagnosis of urological disorders and the detection of early prostate cancer. It offers ultrasound products that include Portascan+, a portable real-time ultrasound bladder scanner; and Multiscan PVR, a portable real-time bladder scanner for scanning bladder volume. The company also provides urodynamics products, which consist of Urodyn+, a wireless uroflow meter; Portaflow and Portaflow advanced, which provide uroflow data and tracings for male, female, and pediatric patients in various point-of-care environments; Clinic Sensic and Portable Sensic systems, which are urodynamics s...

Lumonics House

Valley Drive

Swift Valley

Rugby,  CV21 1TQ

United Kingdom

Founded in 1996

59 Employees


44 17 8854 7888


44 17 8853 6434

Key Executives for Mediwatch plc

Chief Executive Officer and Executive Director
Chief Financial Officer
Age: 58
Head of Production
Head of Operations
Head of Services
Compensation as of Fiscal Year 2014.

Mediwatch plc Key Developments

Mediwatch plc Announces Unaudited Consolidated Earnings Results for the Six Months Ended April 30, 2013

Mediwatch plc announced unaudited consolidated earnings results for the six months ended April 30, 2013. For the six months, the company’s revenue was £4,911,000 against £5,084,000 a year ago. Profit from operating activities was £161,000 against £78,000 a year ago. Profit before taxation was £121,000 against £39,000 a year ago. Profit for the period attributable to the equity shareholders was £121,000 or 0.09 pence per basic and diluted share against £39,000 or 0.03 pence per basic and diluted share a year ago. Net cash used in operating activities was £61,000 against net cash from operating activities of £163,000 a year ago. Purchase of property, plant & equipment was £52,000 for the six months ended March 31, 2013. Purchase of intangible fixed assets was £263,000 against £363,000 a year ago. The group achieved an EBITDA of £311,000 for the six months to April 30, 2013 compared to £245,000 for the first half year 2012.  Profit is very slightly ahead of the board's expectations at this stage. Cash flow was down due to increasing working capital requirement in the USA from the increasing sales.

Mediwatch plc Dissolves Joint Venture with Genesis Medical Ltd

Mediwatch plc announced that after lengthy negotiations with Genesis Medical Ltd. regarding the joint venture, both parties could not agree on a number of commercial aspects and the joint venture has been dissolved. Mediwatch plc has therefore decided to reorganise its UK sales management and has utilised existing in-house personnel to extend coverage in the UK without incurring additional overhead costs. This will enable Mediwatch to prepare for the release of newly designed products and will give Mediwatch control of the UK market place.

Mediwatch plc, Annual General Meeting, Apr 22, 2013

Mediwatch plc, Annual General Meeting, Apr 22, 2013., at 11:00 GMT Standard Time. Location: Lumonics House.

Similar Private Companies By Industry

Company Name Region
Genesis Diagnostics Ltd Europe
CellPath Ltd. Europe
Hallmarq Veterinary Imaging Ltd Europe
Cirdan Ultra Ltd. Europe
Clement Clarke International Limited Europe

Recent Private Companies Transactions

November 18, 2013

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Mediwatch plc, please visit www.mediwatch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.